Kurreck, A., Geissler, M., Martens, U. M., Riera-Knorrenschild, J., Greeve, J., Florschütz, A., . . . Modest, D. P. (2020). Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: Analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109). J Cancer Res Clin Oncol.
Chicago Style citaatKurreck, A., et al. "Dynamics in Treatment Response and Disease Progression of Metastatic Colorectal Cancer (mCRC) Patients With Focus On BRAF Status and Primary Tumor Location: Analysis of Untreated RAS-wild-type MCRC Patients Receiving FOLFOXIRI Either With or Without Panitumumab in the VOLFI Trial (AIO KRK0109)." J Cancer Res Clin Oncol 2020.
MLA citatieKurreck, A., et al. "Dynamics in Treatment Response and Disease Progression of Metastatic Colorectal Cancer (mCRC) Patients With Focus On BRAF Status and Primary Tumor Location: Analysis of Untreated RAS-wild-type MCRC Patients Receiving FOLFOXIRI Either With or Without Panitumumab in the VOLFI Trial (AIO KRK0109)." J Cancer Res Clin Oncol 2020.